Press Releases from P&S Market Research- Pharmaceuticals (18 total)
Benign Prostatic Hyperplasia Therapeutics Market - Epidemiology Analysis, Therap …
The global benign prostatic hyperplasia therapeutics market is expected to witness significant growth, as increased number of effective treatments are available for cancer. Increasing awareness…
Global Esophageal Cancer Therapeutics Market Analysis, Development and Demand Fo …
Global esophageal cancer therapeutics market is expected to witness significant growth with an increasing awareness regarding cancer treatment and technological advancements. Also, high demand for…
Pancreatic Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Developm …
The global pancreatic cancer therapeutics market holds numerous opportunities for the key players, as pancreatic cancer is a highly challenging disease among all types of…
Novel Targets for Breast Cancer Treatment Drive Estrogen Receptor-Positive (ER+) …
Estrogen Receptor-Positive (ER+) breast cancer currently exhibits a pipeline with 46 active drug candidates.
ER+ breast cancer pipeline offers novel therapeutic targets for the treatment of…
Serine/Threonine-Protein Kinase Inhibitors Pipeline Analysis, 2016
Serine/threonine-protein kinases (EC 2.7.11.1) are enzyme or protein that has hydroxyl (OH) group in the side chain. Phosphorylation in serine or threonine residues may cause…
Increasing prevalence of cancer drives Global Cancer/Tumor Profiling Market
Increasing prevalence of cancer drives the global market
According to the study, the global cancer/tumor profiling market is likely to grow significantly, during the forecast period,…
BACE Inhibitors Exhibit an Emerging Pipeline with 10+ Drug Candidates
BACE inhibitors offer novel therapeutic approach for the treatment of Alzheimer’s disease
The study analyzed that the Beta Secretase inhibitors pipeline comprised 15 drug candidates, of…
BET Inhibitors Exhibit an Emerging Pipeline with 35+ Drug Candidates
BET inhibitors currently exhibit a strong pipeline with estimated 38 drug candidates.
BET inhibitors offer novel therapeutic approach for cancer
The study analyzed that the BET inhibitors…
Vasomotor Symptoms of Menopause Therapeutics Pipeline Analysis, 2016
Vasomotor symptoms occur when a woman reach the state of menopause and ovaries stop producing eggs, and there is a reduction in secretion of hormones…
Phosphoinositide 3-Kinase Inhibitor Pipeline Analysis, 2016 by P&S Market Resear …
Phosphoinositide 3-kinase (PI3K) pathway regulates a number of processes such as cell growth, metabolism, survival, cell migration, protein synthesis, metabolism and proliferation. It also plays…
Interstitial Cystitis (IC) Disease Pipeline Analysis by P&S Market Research
Interstitial Cystitis (IC) is a painful bladder syndrome in which inflamed and irritated bladder cause recurring discomfort or pain. The symptoms of IC include an…
Lysosomal Storage Disorders Pipeline Analysis, 2016 by P&S Market Research
The deficiency of lysosomal enzymes cause lysosomal storage disorders (LSDs). It occurs due to mutations of genes that encode proteins, enzyme and related cofactors. There…
Janus Kinase (JAK) Inhibitors Pipeline Analysis, 2016 by P&S Market Research
Janus kinase (JAK) inhibitors block Janus kinase activator enzymes and interrupt signaling pathway. It plays an important role in host defense, oncology, autoimmunity and hematological…
Hepcidin antagonist, Pipeline Analysis, 2016 by P&S Market Research
Hepcidin is a small peptide which acts as iron regulatory hormone. The name ‘hepcidin’ is taken from the place of synthesis in hepatocytes (hep), whereas…
Fungal Infections Pipeline Analysis, 2016 by P&S Market Research
Fungal Infection is a major cause of morbidity worldwide. Fungal Infections are caused by different fungi found in environment. Although, some fungi are not dangerous…
Estrogen Receptor-Positive Breast Cancer Pipeline Analysis, 2016
Estrogen receptor-positive breast cancer is the most common female cancer globally. Cancer that is positive for estrogen-receptor are called estrogen receptor (ER) -positive cancer. It…
AKT/Protein Kinase B (PKB) Inhibitors Pipeline Analysis, 2016 by P&S Market Rese …
AKT, also known as Protein Kinase B (PKB), is overexpressed or activated in large number of human cancers, including breast, lung, gastric, ovary and pancreas.…
Idiopathic Pulmonary Fibrosis (IPF) Pipeline, A Novel Advancement for the Treatm …
The study analyzed that the IPF pipeline comprised of 97 therapeutic candidates, of which 15 are in Phase II stage of development. The lack of…
Go To Page:
